Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CabotFRA:CBT 81 9-Day RSI is 52.32 as of Jul. 15, 2026. GuruFocus rates FRA:CBT with a GF Score™ of 81/100 and a GF Value™ of €65.83 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,649 Chemicals companies, Cabot ranks worse than 70.65% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-15), Cabot's 9-Day RSI is 52.32.
The industry rank for Cabot's 9-Day RSI or its related term are showing as below:
FRA:CBT's 9-Day RSI is ranked worse than 70.65% of 1649
companies
in the Chemicals industry
Industry Median: 42.32
vs FRA:CBT: 52.32
Cabot (FRA:CBT) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Cabot 9-Day RSI Related Terms
FRA:CBT vs SXT, BCPC, PRM: 9-Day RSI Comparison
For the Specialty Chemicals subindustry, Cabot's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cabot 9-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cabot's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Cabot's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cabot (FRA:CBT) has a 9-Day RSI of 52.32 as of Jul. 15, 2026. According to the industry distribution chart, Cabot ranks #1165 out of 1649 companies in the Chemicals industry, placing it in the top 70.6%.
Is Cabot's 9-Day RSI too high?
Cabot's current 9-Day RSI is 52.32. The Chemicals industry median 9-Day RSI is 42.32. Cabot's value of 52.32 is 23.6% above this industry median. Based on the distribution chart, Cabot ranks #1165 out of 1649 companies in the Chemicals industry, which is below the industry midpoint. Overall, Cabot has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cabot's 9-Day RSI compare to SXT and BCPC?
According to the Chemicals industry distribution chart, Cabot ranks #1165 out of 1649 companies for 9-Day RSI. This places Cabot in the lower half of its industry. The industry median 9-Day RSI is 42.32. Cabot's value of 52.32 is 23.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Chemicals company?
The median 9-Day RSI among Chemicals companies is 42.32, based on 1,649 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cabot's current 9-Day RSI of 52.32 is 23.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median 9-Day RSI is 42.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cabot's current 9-Day RSI is 52.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabot stock overvalued right now?
Based on GuruFocus' analysis, Cabot (FRA:CBT) is currently considered Modestly Overvalued. The stock's GF Value™ is €65.83, compared to a current price of €76.30 — trading 15.9% above its estimated fair value. The current 9-Day RSI is 52.32 and 23.6% above the Chemicals industry median of 42.32. Cabot's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Cabot (FRA:CBT), the current 9-Day RSI is 52.32 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cabot (FRA:CBT) Overvalued in 2026?
Based on GuruFocus' analysis, Cabot stock appears to be overvalued.
The current stock price of €76.30 is trading 15.9% above its estimated GF Value™ of €65.83.
GuruFocus considers Cabot to be Modestly Overvalued.
Key valuation signals for FRA:CBT:
9-Day RSI: 52.32
GF Value™: €65.83 vs. price of €76.30 (15.9% above fair value)
Industry Position: 23.6% above the Chemicals median (#1165 of 1649)
No single metric tells the full story. See the FRA:CBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
81GF Score
Get the complete analysis for FRA:CBT
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CBT has been successfully added to your 
